{
    "2019-02-03": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Pfizer's Next 3 Years: What Investors Can Expect",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "investors",
                        "expect"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "A War on High Drug Prices Could Boost Biosimilars",
                "features": {
                    "keywords": [
                        "war",
                        "drug prices",
                        "biosimilars"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pfizer's Next 3 Years: What Investors Can Expect",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "investors",
                        "expect"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}